Articles From: Angie's List's stock surges on strong results, but Janney analyst will 'wait and see' to Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2014 Financial Results Conference Call


2015/2/18
The 48% surge in Angie's List's stock (ANGI) to a four-month high Wednesday, after better-than-expected fourth-quarter results, isn't enough to turn Janney Capital Markets bullish.
Sign-up for Angie's List's stock surges on strong results, but Janney analyst will 'wait and see' investment picks
2014/12/9
ALBANY, N.Y., Dec.
Sign-up for AngioDynamics Awarded HealthTrust PICC Contract investment picks
2015/1/29
ALBANY, N.Y., Jan.
Sign-up for AngioDynamics Receives Expanded "No Chest X-Ray" FDA Clearance for Celerity Tip Location System investment picks
2015/1/8
Second Quarter Fiscal 2015 Net Sales increased 4% to $92.1 million; 5% sales growth excluding supply agreement GAAP EPS of $0.04; Non-GAAP adjusted net income of $0.17 per share, a 21% YOY increase EBITDA of $11.9 million; Adjusted EBITDA of $15.9 million, a 18% YOY increase Company raises full-year adjusted EPS guidance to $0.66-$0.72 ALBANY, N.Y., Jan.
Sign-up for AngioDynamics Reports 2015 Second Quarter Financial Results investment picks
2015/1/6
ALBANY, N.Y., Jan.
Sign-up for AngioDynamics to Present at 33rd Annual J.P. Morgan Healthcare Conference investment picks
2014/12/17
ALBANY, N.Y., Dec.
Sign-up for AngioDynamics to Report Fiscal 2015 Second Quarter Financial Results investment picks
2015/2/13
By Ian Walker And Scott Patterson Anglo American PLC on Friday provided fresh evidence of the toll that slumping commodity prices are taking on the global mining industry, reporting a $2.51 billion loss for 2014 and slashing the value of an important Brazilian iron mine.
Sign-up for Anglo American Reports Another Net Loss on Write-Downs -- 2nd Update investment picks
2015/1/28
By Alex MacDonald LONDON --
Sign-up for Anglo American warns of hit from slide in commodity prices investment picks
2014/12/12
LONDON, UNITED KINGDOM --
Sign-up for Anglo Pacific Group PLC Announces Scrip Dividend Circular Released investment picks
2015/2/6
LONDON, UNITED KINGDOM --
Sign-up for Anglo Pacific Group PLC Publication of Prospectus and Circular and Launch of Open Offer investment picks
2014/12/9
LONDON, UNITED KINGDOM --
Sign-up for Anglo Pacific Group PLC: Director's Share Dealings investment picks
2015/2/17
LONDON, UNITED KINGDOM --
Sign-up for Anglo Pacific Group PLC: TR-1: Notification of Major Interest in Shares investment picks
2015/2/13
LONDON, UNITED KINGDOM --
Sign-up for Anglo Pacific Group PLC: TR-1: Notification of Major Interest in Shares investment picks
2015/2/12
LONDON, UNITED KINGDOM --
Sign-up for Anglo Pacific Group PLC: TR-1: Notification of Major Interest in Shares investment picks
2015/2/13
By Ian Walker And Scott Patterson LONDON--
Sign-up for Anglo Reports Another Net Loss on Write-Downs investment picks
2015/2/13
By Ian Walker And Scott Patterson LONDON--
Sign-up for Anglo Reports Another Net Loss on Write-Downs--Update investment picks
2015/2/10
By Alexandra Wexler CAPE TOWN--AngloGold Ashanti (AU), the world's third-largest gold producer, is still considering a joint operation or sale of an asset for full value to help reduce debt, the firm's chief executive, Srinivasan Venkatakrishnan, told the Indaba mining conference in Cape Town on Tuesday.
Sign-up for AngloGold Ashanti Still Considering Asset Sales, Joint Ventures investment picks
2015/2/23
http://www.marketwire.com/library/MwGo/2015/2/23/11G033796/AngloGold_Ashanti-1123520250393.jpg JOHANNESBURG, SOUTH AFRICA--(Marketwired - February 23, 2015) - AngloGold Ashanti (NYSE: AU) today posted its second consecutive growth in annual production alongside a 13% improvement in all-in sustaining costs, as it continued to focus on portfolio improvements and capital discipline.
Sign-up for AngloGold Output Rises for 2nd Straight Year; Costs Fall 13% investment picks
2015/2/24
FRANKFURT--The following is a summary of analysts' forecasts for Anheuser-Busch InBev (ABI.BT) fourth-quarter results, based on a poll of eight analysts conducted by Dow Jones Newswires (figures in million dollars, EPS and dividend in dollar, target price in euro, according to IFRS). Earnings figures are scheduled to be released February 26.
Sign-up for Anheuser-Busch InBev 4Q 2014 -- Forecast investment picks
2015/2/12
Why A-B would want them: Because every brewer worth their beer wants to be in Asheville.
Sign-up for Anheuser-Busch should buy these craft beer -2- investment picks
2015/2/12
By Jason Notte, MarketWatch The conglomerate has been on a buying spree as craft takes market share Start your breathing exercises and pick your mantras now, craft beer groupies: Anheuser-Busch InBev is going to buy another brewery.
Sign-up for Anheuser-Busch should buy these craft beer brewers next investment picks
2015/2/3
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Announces Appointment of Dr. David Sullivan to VP of Quality Operations investment picks
2014/12/5
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Announces Pricing of Upsized $125 Million Convertible Notes Offering investment picks
2015/1/30
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Announces the Launch of Etodolac 300mg Capsules investment picks
2014/12/11
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Presents At Oppenheimer 25th Annual Healthcare Conference investment picks
2015/2/19
For the fourth quarter 2014: - Record net revenues of $21.0 million, an increase of 100% over fourth quarter 2013 - Record adjusted non-GAAP EBITDA of $12.8 million, an increase of 225% over fourth quarter 2013 - Adjusted non-GAAP diluted earnings per share of $1.94, which includes the positive impact of a $16.7 million deferred tax valuation allowance reversal For the full year ended December 31, 2014: - Record annual revenues of $56.0 million, an increase of 86% over 2013 - Record adjusted non-GAAP EBITDA of $27.3 million, an increase of 264% over 2013 - Adjusted non-GAAP diluted earnings per share of $2.96, which includes the positive impact of a $16.7 million deferred tax valuation allowance reversal BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Reports Record Fourth Quarter and Full Year 2014 Financial Results investment picks
2015/2/12
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Schedules Conference Call for Fourth Quarter and Full Year 2014 Financial Results investment picks
2014/12/4
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals, Inc. Announces $100 Million Public Offering of Convertible Notes investment picks
2015/2/12
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that it plans to issue its fourth-quarter and year-end 2014 financial results after the close of the market on Wednesday, February 25, 2015.
Sign-up for Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2014 Financial Results Conference Call investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Angie's List's stock surges on strong results, but Janney analyst will 'wait and see' to Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2014 Financial Results Conference Call
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent